Dr. Igor Barjaktarevic, MD
Claim this profileUniversity of California Los Angeles
Studies Chronic Obstructive Pulmonary Disease
Studies Lung Disease
5 reported clinical trials
6 drugs studied
Affiliated Hospitals
Clinical Trials Igor Barjaktarevic, MD is currently running
Doxycycline
for Emphysema in HIV
The purpose of this study is to determine if doxycycline will reduce progression of emphysema in people living with HIV. The secondary objectives are to examine the effects of doxycycline on change in quantity of emphysema, six minute walk distance, patient reported outcomes, ratio of forced expiratory volume in 1 second and forced vital capacity. Secondary objectives will also describe the safety and tolerability of doxycycline and determine if doxycycline is associated with development of antibiotic-resistant bacterial infections.
Recruiting0 awards Phase 2
Revefenacin
for COPD-Related Respiratory Insufficiency
RARICO is a pragmatic, randomized, controlled, double-blinded, multi-center trial evaluating the safety and feasibility of nebulized revefenacin in comparison to nebulized ipratropium in patients with COPD and acute respiratory failure requiring invasive mechanical ventilation.
Recruiting3 awards Phase 25 criteria
More about Igor Barjaktarevic, MD
Clinical Trial Related2 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Igor Barjaktarevic, MD has experience with
- Placebo
- Ipratropium Bromide
- Revefenacin Inhalation Solution [Yupelri]
- Doxycycline
- Ensifentrine
- Alpha-1 15%
Breakdown of trials Igor Barjaktarevic, MD has run
Chronic Obstructive Pulmonary Disease
Lung Disease
Hypoxemic Respiratory Failure
Acute Respiratory Failure
Emphysema
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Igor Barjaktarevic, MD specialize in?
Igor Barjaktarevic, MD focuses on Chronic Obstructive Pulmonary Disease and Lung Disease. In particular, much of their work with Chronic Obstructive Pulmonary Disease has involved treating patients, or patients who are undergoing treatment.
Is Igor Barjaktarevic, MD currently recruiting for clinical trials?
Yes, Igor Barjaktarevic, MD is currently recruiting for 2 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Igor Barjaktarevic, MD has studied deeply?
Yes, Igor Barjaktarevic, MD has studied treatments such as Placebo, Ipratropium Bromide, Revefenacin Inhalation Solution [Yupelri].
What is the best way to schedule an appointment with Igor Barjaktarevic, MD?
Apply for one of the trials that Igor Barjaktarevic, MD is conducting.
What is the office address of Igor Barjaktarevic, MD?
The office of Igor Barjaktarevic, MD is located at: University of California Los Angeles, Los Angeles, California 90095 United States. This is the address for their practice at the University of California Los Angeles.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.